MedTrace Logo

PK/PD Clinical Trial of YYD601 in Healthy Adult Male

NCT03558477 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-06-15

No results posted yet for this study

Summary

A dose block-randomized, open-label, parallel clinical trial

Conditions

  • GERD

Interventions

DRUG

YYD601 1

YYD601 1

DRUG

YYD601 2

YYD601 2

DRUG

YYD601 3

YYD601 3

DRUG

Nexium

Nexium

Sponsors & Collaborators

  • Yooyoung Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-19
Primary Completion
2018-02-07
Completion
2018-02-07

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03558477 on ClinicalTrials.gov